share_log

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.65%),Deep Track Biotechnology Master Fund, Ltd.(9.65%), etc.

SEC announcement ·  Feb 14 08:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more